Clinical Utility of the Combined Use of CA19-9 and DUPAN-2 in Pancreatic Adenocarcinoma.
Sumiyoshi T, Uemura K, Shintakuya R, Okada K, Baba K, Harada T, Serikawa M, Ishii Y, Nakamura S, Arihiro K, Murakami Y, Takahashi S.
Sumiyoshi T, et al. Among authors: baba k.
Ann Surg Oncol. 2024 Apr 23. doi: 10.1245/s10434-024-15221-z. Online ahead of print.
Ann Surg Oncol. 2024.
PMID: 38652196